Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Case Report

Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicines

Hyo Jeong Oh, Young Mi Mok, Moon Seong Baek, Ji Kyeong Lee, Bong Soo Seo, Tae Hyeon Kim, Keum Ha Choi, In Kyeom Hwang, Ji Eun Ra, Yong-Reol Oh, Yong Sung Kim, Eun Young Cho, Haak Cheoul Kim, Young Woo Sohn

Clin Mol Hepatol. 2013;19(3):305-308. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.305

View: 11691 Download: 97 Crossref: 5

Review

Drug-induced liver injury: present and future

Ki Tae Suk, Dong Joon Kim

Clin Mol Hepatol. 2012;18(3):249-257. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.249

View: 18384 Download: 309 Crossref: 104

4

Four cases of toxic Liver injury associated with Dictamnus dasycarpus

Jong Soon Jang, M.D., Eui Geun Seo, M.D., Cheol Han, M.D., Hee Bok Chae, M.D., Soon Je Kim, M.D. Jae Dong Lee, M.D. Joon Ho Wang, M.D.

Clin Mol Hepatol. 2008;14(2):206-212. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.206

View: 5781 Download: 69 Crossref: 23

1 |

Viewed By 4871	MAFLD: How is it different from NAFLD?
Viewed By 4820	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4661	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4398	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4340	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search